L. Arthur Hewitt
Keine laufenden Positionen mehr
Profil
L.
Arthur Hewitt worked as a Director of Scientific Affairs at Shearwater Corp.
in 2002-2003, and at Amgen Canada, Inc. in 2000.
He was also a Vice President of Drug Development at Ivory Capital Corp.
in 2005.
From 2011 to 2014, he served as the Chief Scientific Officer and Vice President at Chelsea Therapeutics International Ltd.
Hewitt holds a doctorate degree from the University of Montréal.
Ehemalige bekannte Positionen von L. Arthur Hewitt
| Unternehmen | Position | Ende |
|---|---|---|
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Technik-/Wissenschafts-/F&E-Leiter | 23.06.2014 |
| Ivory Capital Corp. | Corporate Officer/Principal | 02.08.2005 |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 10.01.2000 |
Ausbildung von L. Arthur Hewitt
| University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Shearwater Corp.
Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Health Technology |
| Ivory Capital Corp. | Finance |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
